Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mytilineou

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Neuroscience Letters|August 18, 1987
The toxicity of MPTP to dopamine neurons in culture is reduced at high concentrationsL Friedman, C Mytilineou
Journal of Neurochemistry|September 1, 1988
Studies on the metabolism and toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in cultures of embryonic rat mesencephalonC Mytilineou, L Friedman
Biochemical Pharmacology|June 1, 1989
6-Hydroxydopamine toxicity to dopamine neurons in culture: potentiation by the addition of superoxide dismutase and N-acetylcysteineC Mytilineou, P Danias
Journal of Neurochemistry|December 1, 1985
Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ionC Mytilineou, G Cohen
Science (New York, N.Y.)|August 3, 1984
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine destroys dopamine neurons in explants of rat embryo mesencephalonC Mytilineou, G Cohen
Progress in Clinical and Biological Research|January 1, 1982
Pharmacodynamic properties of catecholamine-derived TIQ's and 7-O-methylated metabolites in neuronal systemsG Cohen, C Mytilineou
Advances in Neurology|January 1, 1987
Tissue culture model for studying MPTP toxicity to dopamine neuronsC Mytilineou, G Cohen
Life Sciences|January 21, 1985
Studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)G Cohen, C Mytilineou
Advances in Experimental Medicine and Biology|March 18, 1999
Cell culture models of neuronal degeneration and neuroprotection. Implications for Parkinson's diseaseE T Leonardi, C Mytilineou
Brain Research|December 15, 1978
Development of adrenergic nerve terminals: the effects of decentralizationC Mytilineou, I B Black
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Neuroscience Letters|August 18, 1987
The toxicity of MPTP to dopamine neurons in culture is reduced at high concentrationsL Friedman, C Mytilineou
Journal of Neurochemistry|September 1, 1988
Studies on the metabolism and toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in cultures of embryonic rat mesencephalonC Mytilineou, L Friedman
Biochemical Pharmacology|June 1, 1989
6-Hydroxydopamine toxicity to dopamine neurons in culture: potentiation by the addition of superoxide dismutase and N-acetylcysteineC Mytilineou, P Danias
Journal of Neurochemistry|December 1, 1985
Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ionC Mytilineou, G Cohen
Science (New York, N.Y.)|August 3, 1984
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine destroys dopamine neurons in explants of rat embryo mesencephalonC Mytilineou, G Cohen
Progress in Clinical and Biological Research|January 1, 1982
Pharmacodynamic properties of catecholamine-derived TIQ's and 7-O-methylated metabolites in neuronal systemsG Cohen, C Mytilineou
Advances in Neurology|January 1, 1987
Tissue culture model for studying MPTP toxicity to dopamine neuronsC Mytilineou, G Cohen
Life Sciences|January 21, 1985
Studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)G Cohen, C Mytilineou
Advances in Experimental Medicine and Biology|March 18, 1999
Cell culture models of neuronal degeneration and neuroprotection. Implications for Parkinson's diseaseE T Leonardi, C Mytilineou
Brain Research|December 15, 1978
Development of adrenergic nerve terminals: the effects of decentralizationC Mytilineou, I B Black
Pageof 7